Our Innovative Medical Solutions for Hospitals

At Sunvou, we provide cutting-edge FENO testing devices tailored to meet the diverse needs of hospital environments, supporting both routine clinical use and more specialized respiratory care pathways. Our comprehensive solutions include three flexible pricing models: a Per-Test Pricing Model with no upfront costs, a Device Purchase Model offering significant savings on consumables, and a Three-Year Lease Agreement for cost-effective, long-term access. Each option is carefully structured to simplify procurement processes and provide hospitals with greater financial predictability while maintaining access to advanced diagnostic tools.

These options are designed to enhance clinical efficiency and align with different operational budgets, ensuring that hospitals can effectively manage respiratory health diagnostics, monitor treatment responses, and optimize patient outcomes across various departments. By integrating seamlessly into existing workflows, our solutions help reduce administrative burden and improve overall care delivery. With our state-of-the-art technology and tailored financial plans, we empower healthcare institutions to deliver superior care while maintaining economic efficiency and long-term sustainability.

Three different models of testing and leasing devices with various costs, a tube with pink liquid, and a three-year lease agreement chart with dollar signs.

Per-Test Pricing Model (Device Included):

Hospitals receive the FENO testing device at no upfront cost and pay based on the number of tests conducted. This model offers financial flexibility, allowing institutions to align costs with usage, minimizing initial capital expenditure.

Infographic explaining pay-per-test pricing model for devices, showing a device connected to a computer, a hand holding a remote, test tubes, a coin with a dollar sign, a calculator displaying 330, and a lease agreement for three years, with accompanying text about reduced costs and device purchase options.

Purchase Device (Lower Consumable Price):

Hospitals purchase the FENO testing device upfront, benefiting from a lower cost on consumables (test kits, sensors, etc.). This option is cost-effective for facilities with high testing volumes, offering long-term savings on ongoing operational costs.

Infographic comparing different device pricing and leasing models: Per-Test Pricing, Device Purchase with reduced costs, Device Purchase with a blood glucose monitor, and a Three-Year Lease Agreement

Lease the Device for Three Years:

Hospitals can lease the FENO testing device over a three-year period with manageable monthly payments. This model combines the benefits of spreading the cost over time with the convenience of consistent access to the latest technology, without the need for a large initial capital outlay.